解脲脲原体新生儿呼吸道分离株对抗菌药物的敏感性
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.
作者信息
Matlow A, Th'ng C, Kovach D, Quinn P, Dunn M, Wang E
机构信息
Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
出版信息
Antimicrob Agents Chemother. 1998 May;42(5):1290-2. doi: 10.1128/AAC.42.5.1290.
Abstract
Twenty-one neonatal respiratory isolates of Ureaplasma urealyticum were serotyped, and their susceptibilities to ciprofloxacin, gentamicin, chloramphenicol, erythromycin, azithromycin, and doxycycline were tested. Most patient strains were Ureaplasma urealyticum bv. parvum. Chloramphenicol, doxycycline, and azithromycin had the lowest MICs. This data may be useful when designing prophylactic or therapeutic trials of antibiotics for chronic lung disease of the newborn.
摘要
对21株解脲脲原体新生儿呼吸道分离株进行了血清分型，并检测了它们对环丙沙星、庆大霉素、氯霉素、红霉素、阿奇霉素和强力霉素的敏感性。大多数患者菌株为微小脲原体生物变种。氯霉素、强力霉素和阿奇霉素的最低抑菌浓度最低。这些数据在设计新生儿慢性肺病抗生素预防性或治疗性试验时可能有用。
相似文献
1
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.
Antimicrob Agents Chemother. 1998 May;42(5):1290-2. doi: 10.1128/AAC.42.5.1290.
2
Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates.
Pediatr Infect Dis J. 1992 Jan;11(1):23-9. doi: 10.1097/00006454-199201000-00007.
3
Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
J Antimicrob Chemother. 1999 Apr;43(4):575-8. doi: 10.1093/jac/43.4.575.
4
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
J Chemother. 2011 Apr;23(2):77-9. doi: 10.1179/joc.2011.23.2.77.
5
Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants.
Pediatr Infect Dis J. 1998 Jul;17(7):615-20. doi: 10.1097/00006454-199807000-00008.
6
[Ureaplasma urealyticum and Ureaplasma parvum in etiology of urogenital mixt-infections].
Zh Mikrobiol Epidemiol Immunobiol. 2006 May-Jun(3):93-5.
7
Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
Antimicrob Agents Chemother. 2015 Oct;59(10):6026-31. doi: 10.1128/AAC.00895-15. Epub 2015 Jul 20.
8
Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women.
Scand J Infect Dis. 2001;33(8):604-10. doi: 10.1080/00365540110026782.
9
Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
J Microbiol Immunol Infect. 2016 Jun;49(3):359-62. doi: 10.1016/j.jmii.2014.06.007. Epub 2014 Jul 28.
10
Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.
Drugs. 2001;61(13):1893-9. doi: 10.2165/00003495-200161130-00002.
引用本文的文献
1
Potentially inappropriate prescribing in hospitalised children: a retrospective, cross-sectional study at a tertiary children's hospital in China.
BMJ Open. 2023 May 2;13(5):e068680. doi: 10.1136/bmjopen-2022-068680.
2
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
Front Pediatr. 2022 Mar 9;10:820259. doi: 10.3389/fped.2022.820259. eCollection 2022.
3
Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.
Clin Perinatol. 2015 Dec;42(4):719-38. doi: 10.1016/j.clp.2015.08.003. Epub 2015 Oct 9.
4
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.
Antimicrob Agents Chemother. 2015 Jan;59(1):570-8. doi: 10.1128/AAC.03951-14. Epub 2014 Nov 10.
5
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.
Antimicrob Agents Chemother. 2013 May;57(5):2127-33. doi: 10.1128/AAC.02183-12. Epub 2013 Feb 25.
6
Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.
Am J Obstet Gynecol. 2012 Dec;207(6):475.e1-475.e14. doi: 10.1016/j.ajog.2012.10.871. Epub 2012 Oct 23.
7
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
Antimicrob Agents Chemother. 2009 May;53(5):2020-7. doi: 10.1128/AAC.01349-08. Epub 2009 Mar 9.
8
Does Ureaplasma spp. cause chronic lung disease of prematurity: ask the audience?
Early Hum Dev. 2009 May;85(5):291-6. doi: 10.1016/j.earlhumdev.2008.12.002. Epub 2009 Jan 13.
9
Ureaplasma urealyticum meningitis in an adult patient.
J Clin Microbiol. 2008 Mar;46(3):1141-3. doi: 10.1128/JCM.01628-07. Epub 2008 Jan 3.
10
Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
Respir Res. 2007 Jun 5;8(1):41. doi: 10.1186/1465-9921-8-41.
本文引用的文献
1
Safety, toleration, and pharmacokinetics of intravenous azithromycin.
Antimicrob Agents Chemother. 1996 Nov;40(11):2577-81. doi: 10.1128/AAC.40.11.2577.
2
Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.
Clin Microbiol Rev. 1993 Jan;6(1):69-87. doi: 10.1128/CMR.6.1.69.
3
Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.
Clin Infect Dis. 1993 Aug;17 Suppl 1:S215-8. doi: 10.1093/clinids/17.supplement_1.s215.
4
Therapeutic considerations for Ureaplasma urealyticum infections in neonates.
Clin Infect Dis. 1993 Aug;17 Suppl 1:S208-14. doi: 10.1093/clinids/17.supplement_1.s208.
5
Current status of the mollicute flora of humans.
Clin Infect Dis. 1993 Aug;17 Suppl 1:S2-9. doi: 10.1093/clinids/17.supplement_1.s2.
6
Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation.
Clin Infect Dis. 1993 Aug;17 Suppl 1:S112-6. doi: 10.1093/clinids/17.supplement_1.s112.
7
Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants.
J Pediatr. 1994 Jun;124(6):956-61. doi: 10.1016/s0022-3476(05)83192-0.
8
Efficacy of antibiotic therapy in preventing spontaneous pregnancy loss among couples colonized with genital mycoplasmas.
Am J Obstet Gynecol. 1983 Jan 15;145(2):239-44. doi: 10.1016/0002-9378(83)90499-4.
9
Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy.
Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S288-91. doi: 10.1097/00006454-198611010-00019.
10
Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants.
Pediatr Infect Dis J. 1988 Aug;7(8):542-6.
Zotero 插件